nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Mometasone—systemic scleroderma	0.173	0.468	CbGbCtD
Eszopiclone—CYP2C9—Leflunomide—systemic scleroderma	0.0778	0.21	CbGbCtD
Eszopiclone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0689	0.186	CbGbCtD
Eszopiclone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.028	0.0755	CbGbCtD
Eszopiclone—CYP3A4—Prednisone—systemic scleroderma	0.0223	0.0604	CbGbCtD
Eszopiclone—CYP2C9—cardial valve—systemic scleroderma	0.0183	0.36	CbGeAlD
Eszopiclone—TSPO—artery—systemic scleroderma	0.00451	0.0886	CbGeAlD
Eszopiclone—TSPO—blood vessel—systemic scleroderma	0.00351	0.069	CbGeAlD
Eszopiclone—PTGS1—artery—systemic scleroderma	0.00251	0.0493	CbGeAlD
Eszopiclone—PTGS1—endothelium—systemic scleroderma	0.00212	0.0416	CbGeAlD
Eszopiclone—PTGS1—blood vessel—systemic scleroderma	0.00195	0.0384	CbGeAlD
Eszopiclone—TSPO—connective tissue—systemic scleroderma	0.0018	0.0354	CbGeAlD
Eszopiclone—GABRA4—tendon—systemic scleroderma	0.00175	0.0344	CbGeAlD
Eszopiclone—TSPO—smooth muscle tissue—systemic scleroderma	0.00165	0.0324	CbGeAlD
Eszopiclone—TSPO—skin of body—systemic scleroderma	0.00163	0.032	CbGeAlD
Eszopiclone—TSPO—digestive system—systemic scleroderma	0.0013	0.0256	CbGeAlD
Eszopiclone—GABRB2—lung—systemic scleroderma	0.00128	0.0252	CbGeAlD
Eszopiclone—TSPO—tendon—systemic scleroderma	0.00124	0.0243	CbGeAlD
Eszopiclone—TSPO—lung—systemic scleroderma	0.00109	0.0213	CbGeAlD
Eszopiclone—PTGS1—connective tissue—systemic scleroderma	0.001	0.0197	CbGeAlD
Eszopiclone—PTGS1—smooth muscle tissue—systemic scleroderma	0.000916	0.018	CbGeAlD
Eszopiclone—PTGS1—skin of body—systemic scleroderma	0.000904	0.0178	CbGeAlD
Eszopiclone—CYP2C9—digestive system—systemic scleroderma	0.000792	0.0156	CbGeAlD
Eszopiclone—PTGS1—digestive system—systemic scleroderma	0.000723	0.0142	CbGeAlD
Eszopiclone—PTGS1—tendon—systemic scleroderma	0.000688	0.0135	CbGeAlD
Eszopiclone—CYP3A4—digestive system—systemic scleroderma	0.000604	0.0119	CbGeAlD
Eszopiclone—PTGS1—lung—systemic scleroderma	0.000604	0.0119	CbGeAlD
Eszopiclone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000354	0.000612	CcSEcCtD
Eszopiclone—Osteoarthritis—Methotrexate—systemic scleroderma	0.000354	0.000611	CcSEcCtD
Eszopiclone—Confusional state—Lisinopril—systemic scleroderma	0.000353	0.00061	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000353	0.000609	CcSEcCtD
Eszopiclone—Headache—Mometasone—systemic scleroderma	0.000353	0.000609	CcSEcCtD
Eszopiclone—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000352	0.000608	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000352	0.000607	CcSEcCtD
Eszopiclone—Insomnia—Mycophenolic acid—systemic scleroderma	0.000352	0.000607	CcSEcCtD
Eszopiclone—Fatigue—Leflunomide—systemic scleroderma	0.000351	0.000607	CcSEcCtD
Eszopiclone—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00035	0.000605	CcSEcCtD
Eszopiclone—Pruritus—Captopril—systemic scleroderma	0.00035	0.000604	CcSEcCtD
Eszopiclone—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000349	0.000603	CcSEcCtD
Eszopiclone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000602	CcSEcCtD
Eszopiclone—Pain—Leflunomide—systemic scleroderma	0.000348	0.000602	CcSEcCtD
Eszopiclone—Constipation—Leflunomide—systemic scleroderma	0.000348	0.000602	CcSEcCtD
Eszopiclone—Infection—Lisinopril—systemic scleroderma	0.000348	0.000601	CcSEcCtD
Eszopiclone—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000347	0.0006	CcSEcCtD
Eszopiclone—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000346	0.000598	CcSEcCtD
Eszopiclone—Somnolence—Mycophenolic acid—systemic scleroderma	0.000345	0.000597	CcSEcCtD
Eszopiclone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000596	CcSEcCtD
Eszopiclone—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000593	CcSEcCtD
Eszopiclone—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000342	0.000591	CcSEcCtD
Eszopiclone—Tachycardia—Lisinopril—systemic scleroderma	0.000342	0.00059	CcSEcCtD
Eszopiclone—Body temperature increased—Azathioprine—systemic scleroderma	0.000341	0.000589	CcSEcCtD
Eszopiclone—Abdominal pain—Azathioprine—systemic scleroderma	0.000341	0.000589	CcSEcCtD
Eszopiclone—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000585	CcSEcCtD
Eszopiclone—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000338	0.000584	CcSEcCtD
Eszopiclone—Diarrhoea—Captopril—systemic scleroderma	0.000338	0.000584	CcSEcCtD
Eszopiclone—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000338	0.000583	CcSEcCtD
Eszopiclone—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000583	CcSEcCtD
Eszopiclone—Irritability—Methotrexate—systemic scleroderma	0.000337	0.000583	CcSEcCtD
Eszopiclone—Erectile dysfunction—Prednisone—systemic scleroderma	0.000337	0.000582	CcSEcCtD
Eszopiclone—Feeling abnormal—Leflunomide—systemic scleroderma	0.000336	0.00058	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000336	0.000579	CcSEcCtD
Eszopiclone—Fatigue—Mycophenolic acid—systemic scleroderma	0.000335	0.000579	CcSEcCtD
Eszopiclone—Mood swings—Methotrexate—systemic scleroderma	0.000335	0.000578	CcSEcCtD
Eszopiclone—Nausea—Mometasone—systemic scleroderma	0.000334	0.000577	CcSEcCtD
Eszopiclone—Anorexia—Lisinopril—systemic scleroderma	0.000334	0.000576	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000333	0.000575	CcSEcCtD
Eszopiclone—Weight increased—Prednisone—systemic scleroderma	0.000333	0.000575	CcSEcCtD
Eszopiclone—Ataxia—Methotrexate—systemic scleroderma	0.000332	0.000574	CcSEcCtD
Eszopiclone—Pain—Mycophenolic acid—systemic scleroderma	0.000332	0.000574	CcSEcCtD
Eszopiclone—Constipation—Mycophenolic acid—systemic scleroderma	0.000332	0.000574	CcSEcCtD
Eszopiclone—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000574	CcSEcCtD
Eszopiclone—Weight decreased—Prednisone—systemic scleroderma	0.000331	0.000571	CcSEcCtD
Eszopiclone—Dizziness—Captopril—systemic scleroderma	0.000327	0.000565	CcSEcCtD
Eszopiclone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000562	CcSEcCtD
Eszopiclone—Depression—Prednisone—systemic scleroderma	0.000325	0.000561	CcSEcCtD
Eszopiclone—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000324	0.00056	CcSEcCtD
Eszopiclone—Urticaria—Leflunomide—systemic scleroderma	0.000324	0.000559	CcSEcCtD
Eszopiclone—Abdominal pain—Leflunomide—systemic scleroderma	0.000322	0.000556	CcSEcCtD
Eszopiclone—Body temperature increased—Leflunomide—systemic scleroderma	0.000322	0.000556	CcSEcCtD
Eszopiclone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00032	0.000553	CcSEcCtD
Eszopiclone—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000553	CcSEcCtD
Eszopiclone—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000553	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00032	0.000552	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000319	0.000551	CcSEcCtD
Eszopiclone—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000551	CcSEcCtD
Eszopiclone—Hypersensitivity—Azathioprine—systemic scleroderma	0.000318	0.000549	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000318	0.000549	CcSEcCtD
Eszopiclone—Insomnia—Lisinopril—systemic scleroderma	0.000317	0.000547	CcSEcCtD
Eszopiclone—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000316	0.000546	CcSEcCtD
Eszopiclone—Paraesthesia—Lisinopril—systemic scleroderma	0.000314	0.000543	CcSEcCtD
Eszopiclone—Vomiting—Captopril—systemic scleroderma	0.000314	0.000543	CcSEcCtD
Eszopiclone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00054	CcSEcCtD
Eszopiclone—Dyspnoea—Lisinopril—systemic scleroderma	0.000312	0.000539	CcSEcCtD
Eszopiclone—Rash—Captopril—systemic scleroderma	0.000312	0.000538	CcSEcCtD
Eszopiclone—Dermatitis—Captopril—systemic scleroderma	0.000311	0.000538	CcSEcCtD
Eszopiclone—Somnolence—Lisinopril—systemic scleroderma	0.000311	0.000537	CcSEcCtD
Eszopiclone—Headache—Captopril—systemic scleroderma	0.00031	0.000535	CcSEcCtD
Eszopiclone—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000534	CcSEcCtD
Eszopiclone—Dyspepsia—Lisinopril—systemic scleroderma	0.000308	0.000532	CcSEcCtD
Eszopiclone—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000307	0.000531	CcSEcCtD
Eszopiclone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000307	0.000531	CcSEcCtD
Eszopiclone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00053	CcSEcCtD
Eszopiclone—Asthma—Methotrexate—systemic scleroderma	0.000306	0.000528	CcSEcCtD
Eszopiclone—Infection—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000526	CcSEcCtD
Eszopiclone—Decreased appetite—Lisinopril—systemic scleroderma	0.000304	0.000526	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000302	0.000522	CcSEcCtD
Eszopiclone—Fatigue—Lisinopril—systemic scleroderma	0.000302	0.000521	CcSEcCtD
Eszopiclone—Hypersensitivity—Leflunomide—systemic scleroderma	0.0003	0.000518	CcSEcCtD
Eszopiclone—Pain—Lisinopril—systemic scleroderma	0.000299	0.000517	CcSEcCtD
Eszopiclone—Constipation—Lisinopril—systemic scleroderma	0.000299	0.000517	CcSEcCtD
Eszopiclone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000517	CcSEcCtD
Eszopiclone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000512	CcSEcCtD
Eszopiclone—Diarrhoea—Azathioprine—systemic scleroderma	0.000295	0.00051	CcSEcCtD
Eszopiclone—Nausea—Captopril—systemic scleroderma	0.000294	0.000507	CcSEcCtD
Eszopiclone—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000505	CcSEcCtD
Eszopiclone—Asthenia—Leflunomide—systemic scleroderma	0.000292	0.000505	CcSEcCtD
Eszopiclone—Hallucination—Prednisone—systemic scleroderma	0.000291	0.000503	CcSEcCtD
Eszopiclone—Feeling abnormal—Lisinopril—systemic scleroderma	0.000288	0.000498	CcSEcCtD
Eszopiclone—Pruritus—Leflunomide—systemic scleroderma	0.000288	0.000498	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000286	0.000494	CcSEcCtD
Eszopiclone—Dysuria—Methotrexate—systemic scleroderma	0.000286	0.000493	CcSEcCtD
Eszopiclone—Dizziness—Azathioprine—systemic scleroderma	0.000285	0.000493	CcSEcCtD
Eszopiclone—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000281	0.000486	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000483	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000279	0.000482	CcSEcCtD
Eszopiclone—Asthenia—Mycophenolic acid—systemic scleroderma	0.000279	0.000482	CcSEcCtD
Eszopiclone—Diarrhoea—Leflunomide—systemic scleroderma	0.000279	0.000481	CcSEcCtD
Eszopiclone—Urticaria—Lisinopril—systemic scleroderma	0.000278	0.00048	CcSEcCtD
Eszopiclone—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000479	CcSEcCtD
Eszopiclone—Abdominal pain—Lisinopril—systemic scleroderma	0.000277	0.000478	CcSEcCtD
Eszopiclone—Body temperature increased—Lisinopril—systemic scleroderma	0.000277	0.000478	CcSEcCtD
Eszopiclone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000476	CcSEcCtD
Eszopiclone—Pruritus—Mycophenolic acid—systemic scleroderma	0.000275	0.000475	CcSEcCtD
Eszopiclone—Vomiting—Azathioprine—systemic scleroderma	0.000274	0.000474	CcSEcCtD
Eszopiclone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000472	CcSEcCtD
Eszopiclone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000471	CcSEcCtD
Eszopiclone—Drowsiness—Methotrexate—systemic scleroderma	0.000272	0.00047	CcSEcCtD
Eszopiclone—Rash—Azathioprine—systemic scleroderma	0.000272	0.00047	CcSEcCtD
Eszopiclone—Dermatitis—Azathioprine—systemic scleroderma	0.000272	0.000469	CcSEcCtD
Eszopiclone—Depression—Methotrexate—systemic scleroderma	0.000272	0.000469	CcSEcCtD
Eszopiclone—Headache—Azathioprine—systemic scleroderma	0.00027	0.000467	CcSEcCtD
Eszopiclone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000466	CcSEcCtD
Eszopiclone—Dizziness—Leflunomide—systemic scleroderma	0.000269	0.000465	CcSEcCtD
Eszopiclone—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00046	CcSEcCtD
Eszopiclone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000266	0.000459	CcSEcCtD
Eszopiclone—Stomatitis—Methotrexate—systemic scleroderma	0.000266	0.000459	CcSEcCtD
Eszopiclone—Conjunctivitis—Methotrexate—systemic scleroderma	0.000265	0.000457	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000457	CcSEcCtD
Eszopiclone—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000453	CcSEcCtD
Eszopiclone—Pain—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000453	CcSEcCtD
Eszopiclone—Sweating—Methotrexate—systemic scleroderma	0.000261	0.000451	CcSEcCtD
Eszopiclone—Haematuria—Methotrexate—systemic scleroderma	0.00026	0.000449	CcSEcCtD
Eszopiclone—Vomiting—Leflunomide—systemic scleroderma	0.000259	0.000447	CcSEcCtD
Eszopiclone—Alopecia—Prednisone—systemic scleroderma	0.000259	0.000447	CcSEcCtD
Eszopiclone—Hypersensitivity—Lisinopril—systemic scleroderma	0.000258	0.000445	CcSEcCtD
Eszopiclone—Dizziness—Mycophenolic acid—systemic scleroderma	0.000257	0.000444	CcSEcCtD
Eszopiclone—Epistaxis—Methotrexate—systemic scleroderma	0.000257	0.000444	CcSEcCtD
Eszopiclone—Rash—Leflunomide—systemic scleroderma	0.000257	0.000444	CcSEcCtD
Eszopiclone—Dermatitis—Leflunomide—systemic scleroderma	0.000257	0.000443	CcSEcCtD
Eszopiclone—Nausea—Azathioprine—systemic scleroderma	0.000256	0.000443	CcSEcCtD
Eszopiclone—Headache—Leflunomide—systemic scleroderma	0.000255	0.000441	CcSEcCtD
Eszopiclone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000436	CcSEcCtD
Eszopiclone—Asthenia—Lisinopril—systemic scleroderma	0.000251	0.000434	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000433	CcSEcCtD
Eszopiclone—Pruritus—Lisinopril—systemic scleroderma	0.000248	0.000428	CcSEcCtD
Eszopiclone—Vomiting—Mycophenolic acid—systemic scleroderma	0.000247	0.000427	CcSEcCtD
Eszopiclone—Rash—Mycophenolic acid—systemic scleroderma	0.000245	0.000423	CcSEcCtD
Eszopiclone—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000245	0.000423	CcSEcCtD
Eszopiclone—Hepatitis—Methotrexate—systemic scleroderma	0.000245	0.000422	CcSEcCtD
Eszopiclone—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000421	CcSEcCtD
Eszopiclone—Headache—Mycophenolic acid—systemic scleroderma	0.000243	0.00042	CcSEcCtD
Eszopiclone—Pharyngitis—Methotrexate—systemic scleroderma	0.000243	0.000419	CcSEcCtD
Eszopiclone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000419	CcSEcCtD
Eszopiclone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000419	CcSEcCtD
Eszopiclone—Nausea—Leflunomide—systemic scleroderma	0.000242	0.000418	CcSEcCtD
Eszopiclone—Vision blurred—Prednisone—systemic scleroderma	0.00024	0.000415	CcSEcCtD
Eszopiclone—Diarrhoea—Lisinopril—systemic scleroderma	0.00024	0.000414	CcSEcCtD
Eszopiclone—Ill-defined disorder—Prednisone—systemic scleroderma	0.000236	0.000408	CcSEcCtD
Eszopiclone—Anaemia—Prednisone—systemic scleroderma	0.000235	0.000407	CcSEcCtD
Eszopiclone—Agitation—Prednisone—systemic scleroderma	0.000234	0.000404	CcSEcCtD
Eszopiclone—Angioedema—Prednisone—systemic scleroderma	0.000233	0.000402	CcSEcCtD
Eszopiclone—Dizziness—Lisinopril—systemic scleroderma	0.000231	0.0004	CcSEcCtD
Eszopiclone—Erythema multiforme—Methotrexate—systemic scleroderma	0.000231	0.000399	CcSEcCtD
Eszopiclone—Nausea—Mycophenolic acid—systemic scleroderma	0.000231	0.000399	CcSEcCtD
Eszopiclone—Malaise—Prednisone—systemic scleroderma	0.00023	0.000397	CcSEcCtD
Eszopiclone—Vertigo—Prednisone—systemic scleroderma	0.000229	0.000395	CcSEcCtD
Eszopiclone—Tinnitus—Methotrexate—systemic scleroderma	0.000228	0.000394	CcSEcCtD
Eszopiclone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000226	0.00039	CcSEcCtD
Eszopiclone—Vomiting—Lisinopril—systemic scleroderma	0.000223	0.000384	CcSEcCtD
Eszopiclone—Rash—Lisinopril—systemic scleroderma	0.000221	0.000381	CcSEcCtD
Eszopiclone—Convulsion—Prednisone—systemic scleroderma	0.000221	0.000381	CcSEcCtD
Eszopiclone—Dermatitis—Lisinopril—systemic scleroderma	0.000221	0.000381	CcSEcCtD
Eszopiclone—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00038	CcSEcCtD
Eszopiclone—Hypertension—Prednisone—systemic scleroderma	0.00022	0.00038	CcSEcCtD
Eszopiclone—Chills—Methotrexate—systemic scleroderma	0.000219	0.000379	CcSEcCtD
Eszopiclone—Headache—Lisinopril—systemic scleroderma	0.000219	0.000379	CcSEcCtD
Eszopiclone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000375	CcSEcCtD
Eszopiclone—Myalgia—Prednisone—systemic scleroderma	0.000217	0.000375	CcSEcCtD
Eszopiclone—Anxiety—Prednisone—systemic scleroderma	0.000216	0.000373	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—systemic scleroderma	0.000216	0.000373	CcSEcCtD
Eszopiclone—Discomfort—Prednisone—systemic scleroderma	0.000214	0.00037	CcSEcCtD
Eszopiclone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000362	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—systemic scleroderma	0.000208	0.00036	CcSEcCtD
Eszopiclone—Nausea—Lisinopril—systemic scleroderma	0.000208	0.000359	CcSEcCtD
Eszopiclone—Anaphylactic shock—Prednisone—systemic scleroderma	0.000208	0.000359	CcSEcCtD
Eszopiclone—Infection—Prednisone—systemic scleroderma	0.000207	0.000357	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—systemic scleroderma	0.000206	0.000356	CcSEcCtD
Eszopiclone—Tachycardia—Prednisone—systemic scleroderma	0.000203	0.00035	CcSEcCtD
Eszopiclone—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00035	CcSEcCtD
Eszopiclone—Hyperhidrosis—Prednisone—systemic scleroderma	0.000201	0.000347	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—systemic scleroderma	0.000201	0.000347	CcSEcCtD
Eszopiclone—Anorexia—Prednisone—systemic scleroderma	0.000198	0.000342	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000198	0.000341	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—systemic scleroderma	0.000197	0.00034	CcSEcCtD
Eszopiclone—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000337	CcSEcCtD
Eszopiclone—Rash—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000334	CcSEcCtD
Eszopiclone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000334	CcSEcCtD
Eszopiclone—Headache—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000332	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—systemic scleroderma	0.000192	0.000332	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—systemic scleroderma	0.000191	0.00033	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000189	0.000327	CcSEcCtD
Eszopiclone—Insomnia—Prednisone—systemic scleroderma	0.000188	0.000325	CcSEcCtD
Eszopiclone—Paraesthesia—Prednisone—systemic scleroderma	0.000187	0.000322	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—systemic scleroderma	0.000184	0.000319	CcSEcCtD
Eszopiclone—Dyspepsia—Prednisone—systemic scleroderma	0.000183	0.000316	CcSEcCtD
Eszopiclone—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000315	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—systemic scleroderma	0.000181	0.000313	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—systemic scleroderma	0.000181	0.000313	CcSEcCtD
Eszopiclone—Decreased appetite—Prednisone—systemic scleroderma	0.000181	0.000312	CcSEcCtD
Eszopiclone—Fatigue—Prednisone—systemic scleroderma	0.000179	0.00031	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—systemic scleroderma	0.000179	0.000309	CcSEcCtD
Eszopiclone—Constipation—Prednisone—systemic scleroderma	0.000178	0.000307	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—systemic scleroderma	0.000175	0.000303	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000174	0.0003	CcSEcCtD
Eszopiclone—Infection—Methotrexate—systemic scleroderma	0.000173	0.000298	CcSEcCtD
Eszopiclone—Feeling abnormal—Prednisone—systemic scleroderma	0.000171	0.000296	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00017	0.000294	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000168	0.00029	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—systemic scleroderma	0.000166	0.000286	CcSEcCtD
Eszopiclone—Urticaria—Prednisone—systemic scleroderma	0.000165	0.000285	CcSEcCtD
Eszopiclone—Body temperature increased—Prednisone—systemic scleroderma	0.000164	0.000284	CcSEcCtD
Eszopiclone—Abdominal pain—Prednisone—systemic scleroderma	0.000164	0.000284	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000158	0.000273	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—systemic scleroderma	0.000157	0.000271	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—systemic scleroderma	0.000156	0.000269	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—systemic scleroderma	0.000155	0.000268	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—systemic scleroderma	0.000154	0.000267	CcSEcCtD
Eszopiclone—Hypersensitivity—Prednisone—systemic scleroderma	0.000153	0.000265	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—systemic scleroderma	0.000153	0.000264	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—systemic scleroderma	0.000151	0.000261	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00015	0.000259	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—systemic scleroderma	0.00015	0.000259	CcSEcCtD
Eszopiclone—Asthenia—Prednisone—systemic scleroderma	0.000149	0.000258	CcSEcCtD
Eszopiclone—Pain—Methotrexate—systemic scleroderma	0.000149	0.000257	CcSEcCtD
Eszopiclone—Pruritus—Prednisone—systemic scleroderma	0.000147	0.000254	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—systemic scleroderma	0.000143	0.000247	CcSEcCtD
Eszopiclone—Diarrhoea—Prednisone—systemic scleroderma	0.000142	0.000246	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000142	0.000245	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—systemic scleroderma	0.000138	0.000238	CcSEcCtD
Eszopiclone—Dizziness—Prednisone—systemic scleroderma	0.000137	0.000237	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—systemic scleroderma	0.000137	0.000237	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—systemic scleroderma	0.000137	0.000237	CcSEcCtD
Eszopiclone—Vomiting—Prednisone—systemic scleroderma	0.000132	0.000228	CcSEcCtD
Eszopiclone—Rash—Prednisone—systemic scleroderma	0.000131	0.000226	CcSEcCtD
Eszopiclone—Dermatitis—Prednisone—systemic scleroderma	0.000131	0.000226	CcSEcCtD
Eszopiclone—Headache—Prednisone—systemic scleroderma	0.00013	0.000225	CcSEcCtD
Eszopiclone—Hypersensitivity—Methotrexate—systemic scleroderma	0.000128	0.000221	CcSEcCtD
Eszopiclone—Asthenia—Methotrexate—systemic scleroderma	0.000125	0.000215	CcSEcCtD
Eszopiclone—Nausea—Prednisone—systemic scleroderma	0.000123	0.000213	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—systemic scleroderma	0.000123	0.000212	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—systemic scleroderma	0.000119	0.000205	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—systemic scleroderma	0.000115	0.000198	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—systemic scleroderma	0.00011	0.000191	CcSEcCtD
Eszopiclone—Rash—Methotrexate—systemic scleroderma	0.00011	0.000189	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—systemic scleroderma	0.000109	0.000189	CcSEcCtD
Eszopiclone—Headache—Methotrexate—systemic scleroderma	0.000109	0.000188	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—systemic scleroderma	0.000103	0.000178	CcSEcCtD
